DNA methylation signatures as predictive biomarkers for chemotherapy (CT) resistance and survival in pancreatic ductal adenocarcinoma (PDA).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410815211
